The presence of some fungal species in tumors predicts – and may even help drive – worse cancer outcomes, according to a study from Weill Cornell Medicine and Duke University researchers.
Vaccination with a SARS-CoV-2 mRNA vaccine revealed HIV hiding in immune cells in blood from people with HIV, according to lab research led by Weill Cornell Medicine investigators.
Small proteins that direct immune cells toward sites of infection can also form DNA-bound nanoparticles that can induce chronic, dysfunctional immune responses, according to a new study.
A Cornell multidisciplinary research center that studies chronic fatigue syndrome has received a five-year, $9.5 million grant from the National Institutes of Health – funding that will enable experts to continue work on the mysterious and debilitating condition.
Isabel Perera, assistant professor of government and expert in health, labor and social policy, says concerns of rationing healthcare related to the pandemic are relevant, but pre-existing inequalities in healthcare have existed long before the COVID-19 virus.
An advanced software tool for analyzing DNA sequences from tumor samples has uncovered likely new cancer-driving genes, in a study led by Weill Cornell Medicine researchers.
Dr. Kelly Musick, a Brooks School of Public Policy work-family researcher, has won a prestigious award for an article she co-authored that analyzed earnings patterns after the birth of a child.
A special type of cell, called an osteocyte, may hold the key to some of the mysteries of osteoporosis. A research group led by Karl Lewis, assistant professor of biomedical engineering, is studying osteocytes in unique new ways.
